Clinical trial
A Study That Will Look at the Impact of Immunosuppression on Antibody Production…
NCT00275717 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00275717 |
|---|---|
| Title | A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients. |
| Official title | The Effects of Thymoglobulin on Antibody Screening Cells. |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Kidney Transplant |
| Enrollment | 60 |
| Start date | Mar 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Jan 12, 2006 |
| Last update posted | Dec 22, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: